Key facts
- This page summarizes BioPlus Sponsor LLC's Form 4 filing for BioPlus Acquisition Corp..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2023, 21:17.
BioPlus Sponsor LLC - 05 Jun 2023 Form 4 Insider Report for BioPlus Acquisition Corp.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 05 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2023, 21:17:36 UTC
- Prior SEC filing
- 07 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Explorer Parent LLC, By: Founder Holdings LLC, its managing member, By: Steven Fletcher, a Managing Member, By: /s/ Alex Vieux, a Managing Member
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
BioPlus Sponsor LLC filed Form 4 for BioPlus Acquisition Corp. on 12 Jun 2023.
Change
- Previous filing in this sequence was filed on 07 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIOS
transaction
Class A Ordinary Shares
Conversion of derivative security
- Transaction value
- Shares
- +5,749,999
- Change %
- +653%
- Price
- Shares after
- 6,629,999
- Date
- 05 Jun 2023
- Ownership
- See footnote
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIOS
transaction
Derivative
Class B Ordinary Shares
Conversion of derivative security
- Transaction value
- Shares
- -5,749,999
- Change %
- -100%
- Price
- Shares after
- 1
- Date
- 05 Jun 2023
- Ownership
- See footnote
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 5,749,999
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares.
Footnote F2
Includes (i) 380,000 placement units purchased by BioPlus Sponsor LLC (the "Sponsor") for $10.00 per unit in a private placement transaction with the Issuer and (ii) a Sponsor loan in the amount of $5,000,000 that is convertible into 500,000 additional units. Each such unit consists of one Class A Ordinary Share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction.
Footnote F3
The Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of the Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein.